Treatment with 5-fuorouracil (5-FU) or oxaliplatin of KRAS mutant colorectal carcinomas in mice led to the enrichment of CUB-domain-containing protein 1 positive (CDCP1+) cells [38]. This evidence concerns the gene CDCP1 and colorectal carcinoma.